231 related articles for article (PubMed ID: 11867011)
1. Recent developments in herpesvirus therapy.
Naesens L; De Clercq E
Herpes; 2001 Mar; 8(1):12-6. PubMed ID: 11867011
[TBL] [Abstract][Full Text] [Related]
2. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
Reusser P
J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
[TBL] [Abstract][Full Text] [Related]
3. Antivirals for the treatment of herpesvirus infections.
De Clercq E
J Antimicrob Chemother; 1993 Jul; 32 Suppl A():121-32. PubMed ID: 8407694
[TBL] [Abstract][Full Text] [Related]
4. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
Wutzler P
Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
[TBL] [Abstract][Full Text] [Related]
5. Herpesviruses.
Bowers M
BETA; 1995 Dec; ():33-7. PubMed ID: 11363008
[TBL] [Abstract][Full Text] [Related]
6. Antiviral agents for non-human immunodeficiency virus infections.
Keating MR
Mayo Clin Proc; 1999 Dec; 74(12):1266-83. PubMed ID: 10593357
[TBL] [Abstract][Full Text] [Related]
7. New therapeutic approaches to the alphaherpesvirus infections.
Cassady KA; Whitley RJ
J Antimicrob Chemother; 1997 Feb; 39(2):119-28. PubMed ID: 9069530
[TBL] [Abstract][Full Text] [Related]
8. Drugs for non-HIV viral infections.
Med Lett Drugs Ther; 1997 Aug; 39(1006):69-76. PubMed ID: 9255238
[No Abstract] [Full Text] [Related]
9. Drugs for non-HIV viral infections.
Med Lett Drugs Ther; 2002 Feb; 44(1123):9-16. PubMed ID: 11828264
[No Abstract] [Full Text] [Related]
10. Prophylaxis against herpesvirus infections in transplant recipients.
Ljungman P
Drugs; 2001; 61(2):187-96. PubMed ID: 11270937
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of new antiherpes agents: famciclovir and valacyclovir.
Stein GE
J Am Pharm Assoc (Wash); 1997; NS37(2):157-63. PubMed ID: 9069689
[TBL] [Abstract][Full Text] [Related]
12. Acyclovir--and beyond.
Darby G
J Int Med Res; 1994; 22 Suppl 1():33A-42A. PubMed ID: 8063023
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic developments in cytomegalovirus retinitis.
Hoffman VF; Skiest DJ
Expert Opin Investig Drugs; 2000 Feb; 9(2):207-20. PubMed ID: 11060672
[TBL] [Abstract][Full Text] [Related]
14. New antiherpesvirus agents. Their targets and therapeutic potential.
Alrabiah FA; Sacks SL
Drugs; 1996 Jul; 52(1):17-32. PubMed ID: 8799682
[TBL] [Abstract][Full Text] [Related]
15. Antiviral drugs in development for herpes zoster.
Fiddian AP
Scand J Infect Dis Suppl; 1996; 100():51-4. PubMed ID: 9163026
[TBL] [Abstract][Full Text] [Related]
16. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
Ormrod D; Scott LJ; Perry CM
Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
[TBL] [Abstract][Full Text] [Related]
17. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Faulds D
Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
[TBL] [Abstract][Full Text] [Related]
18. Management of CMV retinitis in HIV infected patients.
Katlama C
Genitourin Med; 1997 Jun; 73(3):169-73. PubMed ID: 9306895
[No Abstract] [Full Text] [Related]
19. New antivirals with activity against varicella-zoster virus.
Gnann JW
Ann Neurol; 1994; 35 Suppl():S69-72. PubMed ID: 8185303
[TBL] [Abstract][Full Text] [Related]
20. Successors to acyclovir.
Easterbrook P; Wood MJ
J Antimicrob Chemother; 1994 Sep; 34(3):307-11. PubMed ID: 7829405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
